concentris research management
concentris research management
  • 109
  • 62 788
ClustALL: Stratifying Decompensated Cirrhosis Patients – Explained by Sara Palomino
decision-for-liver.eu/
Join Sara Palomino, first author of DECISION's ClustALL paper, as she introduces this novel patient #stratification tool designed to enhance the clinical management of acutely decompensated cirrhosis. By using unsupervised clustering, ClustALL uncovers hidden patterns in patient data, offering clinicians valuable insights and a user-friendly online calculator. Learn how this innovative approach helps improve patient outcomes and supports the DECISION project’s mission to better understand cirrhosis at the systems level.
Read the full scientific publication here: translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05386-2
Find the online calculator here: decision-for-liver.eu/for-scientists/clustall-web-application/
The objective of the DECISION project is to enhance the understanding of the pathophysiology of decompensation of #cirrhosis leading to acute-on-chronic liver failure (#ACLF) or death. This consortium will take advantage of already existing large and clinically well-characterized cohorts to ultimately develop prognostic and response tests and combinatorial therapies tailored to the needs of individual patients to decrease the risk of short-term death.
🌐 Visit the DECISION website:
decision-for-liver.eu/
🤳 Follow DECISION on social media:
Twitter / X: Decision4Liver
LinkedIn: www.linkedin.com/company/decision-project/
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847949. This video reflects only the presenter's view and the European Commission is not responsible for any use that may be made of the information it contains.
Video script: Dr. Sara Palomino Echeverria, formerly Navarrabiomed - Public Foundation Miguel Servet
Video production: Dr. Lidia Garcia-Campmany, EF CLIF (European Foundation for the Study of Chronic Liver Failure)
Thumbnail & video description: Tamara Berghammer, concentris research management gmbh
© 2024 DECISION
มุมมอง: 19

วีดีโอ

A-TANGO Masterclass: Reimbursement in Healthcare (Louise Perrault, IMAC)
มุมมอง 108หลายเดือนก่อน
Effective treatment of acute-on-chronic liver failure (#ACLF) is an urgent and unmet need. The A-TANGO consortium tests and evaluates an innovative new treatment that aims to reduce inflammation and improve hepatocyte proliferation by repurposing TAK-242, an antagonist of toll-like receptor 4, in combination with G-CSF (granulocyte colony-stimulating factor). We call this novel combinatorial th...
MICROB-PREDICT - The gut virome and bacteriophages in decompensated liver cirrhosis (Lore Van Espen)
มุมมอง 102หลายเดือนก่อน
microb-predict.eu With focus on the human microbiome to fight cirrhosis, 22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease. The project aims to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (#decompensated #cirrhosis), when such d...
MICROB-PREDICT - Blood-biomarker to stratify cirrhosis patients in the ALB-Trial (Nikolaj Torp)
มุมมอง 302 หลายเดือนก่อน
microb-predict.eu With focus on the human microbiome to fight cirrhosis, 22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease. The project aims to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (#decompensated #cirrhosis), when such d...
MICROB-PREDICT - Multi-omics biomarkers for early identification of Pre-ALCF (Camila Alvarez-Silva)
มุมมอง 373 หลายเดือนก่อน
microb-predict.eu/ With focus on the human microbiome to fight cirrhosis, 22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease. The project aims to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (decompensated #cirrhosis), when such d...
MICROB-PREDICT - Metagenomics-Metaproteomics Pipeline for Biomarker Discovery in ACLF (Peter Treit)
มุมมอง 293 หลายเดือนก่อน
microb-predict.eu With focus on the human microbiome to fight cirrhosis, 22 European institutions join forces in MICROB-PREDICT to improve the prevention and treatment of chronic liver disease. The project aims to identify microbiome-based biomarkers and mechanisms that predict in advance when the body can no longer compensate for the dysfunctional liver (decompensated #cirrhosis), when such de...
A-TANGO - Poster: Alcohol-related liver failure versus infection-induced ACLF (A. Kerbert & J. Pohl)
มุมมอง 583 หลายเดือนก่อน
A-TANGO project website: a-tango.eu/ About A-TANGO: Effective treatment of acute-on-chronic liver failure (#ACLF) is an urgent and unmet need. The A-TANGO consortium tests and evaluates an innovative new treatment that aims to reduce inflammation and improve hepatocyte proliferation by repurposing TAK-242, an antagonist of toll-like receptor 4, in combination with G-CSF (granulocyte colony-stim...
A-TANGO - Poster at EASL: Evolving patterns in the clinical burden of liver cirrhosis (Julian Pohl)
มุมมอง 323 หลายเดือนก่อน
A-TANGO project website: a-tango.eu/ About A-TANGO: Effective treatment of acute-on-chronic liver failure (#ACLF) is an urgent and unmet need. The A-TANGO consortium tests and evaluates an innovative new treatment that aims to reduce inflammation and improve hepatocyte proliferation by repurposing TAK-242, an antagonist of toll-like receptor 4, in combination with G-CSF (granulocyte colony-stim...
A-TANGO Masterclass 2023 - Economic evaluations in liver disease (by Prof. Isabelle Durand-Zaleski)
มุมมอง 474 หลายเดือนก่อน
a-tango.eu/ Effective treatment of acute-on-chronic liver failure (ACLF) is an urgent and unmet need. The A-TANGO consortium tests and evaluates an innovative new treatment that aims to reduce inflammation and improve hepatocyte proliferation by repurposing TAK-242, an antagonist of toll-like receptor 4, in combination with G-CSF (granulocyte colony-stimulating factor). We call this novel combi...
QSPainRelief Masterclass - Patient Partnerships in Research (Deirdre Ryan from Pain Alliance Europe)
มุมมอง 554 หลายเดือนก่อน
qspainrelief.eu/ #QSPainRelief is an international EU-funded research project with 10 partner institutions in 5 European countries and the USA who collaborate to develop an effective combinational treatment of chronic pain in individual patients by an innovative quantitative systems #pharmacology (QSP) #PainRelief approach. In this insightful QSPainRelief Masterclass, Deirdre Ryan, President of...
DECISION Masterclass: Health economic studies in liver diseases by Prof. Isabelle Durand-Zaleski
มุมมอง 1408 หลายเดือนก่อน
DECISION Masterclass: Health economic studies in liver diseases by Prof. Isabelle Durand-Zaleski
REPO-TRIAL: Pre-clinical validation of in-silico therapeutic predictions (Dr. Ana Isabel Casas)
มุมมอง 899 หลายเดือนก่อน
REPO-TRIAL: Pre-clinical validation of in-silico therapeutic predictions (Dr. Ana Isabel Casas)
REPO-TRIAL: Clinical validation of in silico trial prediction (Prof. Dr. Harald Schmidt)
มุมมอง 619 หลายเดือนก่อน
REPO-TRIAL: Clinical validation of in silico trial prediction (Prof. Dr. Harald Schmidt)
REPO-TRIAL: Applied Bioinformatics and Diagnostics (Cristian Nogales, PhD)
มุมมอง 549 หลายเดือนก่อน
REPO-TRIAL: Applied Bioinformatics and Diagnostics (Cristian Nogales, PhD)
REPO-TRIAL: Patents: What they are, what you have to look out for (Dr. Hermann Mucke)
มุมมอง 359 หลายเดือนก่อน
REPO-TRIAL: Patents: What they are, what you have to look out for (Dr. Hermann Mucke)
DECISION Project: Advancing Treatment Strategies for Decompensated Cirrhosis
มุมมอง 5179 หลายเดือนก่อน
DECISION Project: Advancing Treatment Strategies for Decompensated Cirrhosis
DECISION Keynote Lecture by Prof. Paolo Angeli - Natural History of Decompensation
มุมมอง 23110 หลายเดือนก่อน
DECISION Keynote Lecture by Prof. Paolo Angeli - Natural History of Decompensation
QSPainRelief Masterclass - Human biomarkers of nociception (André Mouraux)
มุมมอง 10010 หลายเดือนก่อน
QSPainRelief Masterclass - Human biomarkers of nociception (André Mouraux)
QSPainRelief Masterclass - Smart data in pharmacokinetics and pharmacodynamics (Liesbeth de Lange)
มุมมอง 11910 หลายเดือนก่อน
QSPainRelief Masterclass - Smart data in pharmacokinetics and pharmacodynamics (Liesbeth de Lange)
REPO-TRIAL: Project Overview & Main outcomes (Prof. Dr. Harald Schmidt, MD, PhD, PharmD, FESC)
มุมมอง 12910 หลายเดือนก่อน
REPO-TRIAL: Project Overview & Main outcomes (Prof. Dr. Harald Schmidt, MD, PhD, PharmD, FESC)
REPO-TRIAL: Patent Possibilities in Drug Repurposing (by Kolja Adamczyk)
มุมมอง 164ปีที่แล้ว
REPO-TRIAL: Patent Possibilities in Drug Repurposing (by Kolja Adamczyk)
REPO-TRIAL: NeDRex use case "Inflammatory Bowl Disease"
มุมมอง 63ปีที่แล้ว
REPO-TRIAL: NeDRex use case "Inflammatory Bowl Disease"
REPO-TRIAL: NeDRex use case "Pulmonary Embolism"
มุมมอง 20ปีที่แล้ว
REPO-TRIAL: NeDRex use case "Pulmonary Embolism"
REPO-TRIAL: Introduction to NeDRex
มุมมอง 49ปีที่แล้ว
REPO-TRIAL: Introduction to NeDRex
REPO-TRIAL: Dr. med. Benedikt Frank on the regulatory complexity to get EU clinical trials approved
มุมมอง 94ปีที่แล้ว
REPO-TRIAL: Dr. med. Benedikt Frank on the regulatory complexity to get EU clinical trials approved
REPO-TRIAL: Dr. Hermann Mucke on the project's patent applications and extraordinary team effort
มุมมอง 63ปีที่แล้ว
REPO-TRIAL: Dr. Hermann Mucke on the project's patent applications and extraordinary team effort
REPO-TRIAL: Prof. Dr. med. Daniel Sedding on the regulatory hurdles for clinicial trials in Germany
มุมมอง 134ปีที่แล้ว
REPO-TRIAL: Prof. Dr. med. Daniel Sedding on the regulatory hurdles for clinicial trials in Germany
DECISION Masterclass 2022 - Overview of the effects of LMWH in cirrhosis (Agustín Albillos Martínez)
มุมมอง 178ปีที่แล้ว
DECISION Masterclass 2022 - Overview of the effects of LMWH in cirrhosis (Agustín Albillos Martínez)
A-TANGO Masterclass 2022 - Medical Device Design, Biotechnology and Entrepreneurship (Daniel Green)
มุมมอง 902 ปีที่แล้ว
A-TANGO Masterclass 2022 - Medical Device Design, Biotechnology and Entrepreneurship (Daniel Green)
A-TANGO Masterclass 2022 - Advances in the Treatment of Cirrhosis and ACLF (Prof. Dr. Thomas Berg)
มุมมอง 3.7K2 ปีที่แล้ว
A-TANGO Masterclass 2022 - Advances in the Treatment of Cirrhosis and ACLF (Prof. Dr. Thomas Berg)

ความคิดเห็น

  • @cedricregamey639
    @cedricregamey639 3 ปีที่แล้ว

    I enjoyed the video. I have been trying to search for a vid that breaks down the topics in this vid. The part at 1:06 is knowledgable. Your explanation is like the channel of Doctor Ethan. His demonstrations are for sure knowledgable and he helped me on school! He is a informative Dr in the UK. I suggest you watch his channel out and give the Doctor a subscribe here! ➡️ #FutureDoctorEthan

  • @vanessatracy7445
    @vanessatracy7445 4 ปีที่แล้ว

    I was checking for solution in the internet when i miraculously came Across Dr JOE who is an american base herbalist that Cure Numerous individuals OF HERPES VIRUS (HSV 2) INFECTION, I was diagnosed of herpes virus Match 2nd 2017, then i contacted his Email:via (dr.joeblessed @ gmail. com) and explained everything to him. He mailed me a herbal medication which i took for 2 weeks and was cured of my HERPES VIRUS totally after using his Herbal medicine, So My friend why wait and suffer from this horrible disease when there is someone like Dr JOE that can cure any type of virus and disease such as HIV/ CANCER/ HEPATITIS B VIRUS,LOW SPERM COUNT,ALS,LUPUS VIRUS. email Dr on (dr.joeblessed @ gmail. com) or Whats App him on ‭+234 903 425 8471‬facebook.com/JoewesternHerbs/ drjoeblessed.net

  • @danieldurso5389
    @danieldurso5389 4 ปีที่แล้ว

    consumo . quiero entender como es el tema ,pero no entiendo nada de lo que dice ,

  • @psayent
    @psayent 4 ปีที่แล้ว

    Solid video! Continue the good work. We Would really value your feedback! Let's encourage each other? 😊🙌

  • @gsgsggsgsg7916
    @gsgsggsgsg7916 4 ปีที่แล้ว

    0:18 I will setup your blog and setup it to earn money w h a t s a p p +7 9 6 7 1 5 7 0 5 8 1

  • @laylasleiman1981
    @laylasleiman1981 4 ปีที่แล้ว

    It so obvious that patients with herpes virus are being enslaved to the antiviral drugs that is being prescribed by medical doctors to help suppress and not to cure them completely from the virus they have been battling with "a society that keeps cure a secret so they can continue to sell medication for huge profits is not a real society but a huge mental asylum" I suffered from herpes for three years using medical treatment hoping that one day God will do wonders In my life, a stranger I met at the park felt sorry when she saw the blisters on my face she immediately introduced me to herbalist oduntun from west africa I was convinced that he can cure me completely from the virus so I decided to go into natural remedy with herbalist oduntun. I contacted him on his instagram page @herbalist_oduntun we discussed and he explained everything to me how I will get the herbal medication, the prescription and food diets i will be on while taking the herbal medicine, I was on medication for 21 days following the these rules without eating meat or any diary product. (i'm on plant base🌿 ) I give thanks to God almighty for leading me to the stranger that introduced me to this genuine herbal doctor I'm really grateful🙏🏼 for more information on how to reach him here is his email address: herbalistoduntun@gmail.com or what'sApp number: +2349039463501 here's my email as well: laylalove4life@gmail.com Stay Safe Good luck.

  • @raynava5268
    @raynava5268 4 ปีที่แล้ว

    Excelente informacion saludos😃

  • @joanm.c.
    @joanm.c. 4 ปีที่แล้ว

    Tengo tdah y juropor la vitgensita que a esto no le entro nunca